Ensysce Biosciences (ENSC) News Today $2.47 -0.10 (-3.89%) Closing price 04:00 PM EasternExtended Trading$2.45 -0.02 (-0.81%) As of 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Ensysce Biosciences secures patent for OUD treatmentApril 26, 2025 | uk.investing.comEnsysce Biosciences receives U.S. patent for OUD treatmentApril 25, 2025 | markets.businessinsider.comEnsysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross ProceedsApril 23, 2025 | gurufocus.comEnsysce Biosciences Stock Doubles In One Trading Session - Here's WhyApril 23, 2025 | benzinga.comEnsysce Biosciences announces data from opioid overdose protection studyApril 17, 2025 | markets.businessinsider.comEnsysce Biosciences files to sell 980,000 shares of common stock for holdersApril 17, 2025 | markets.businessinsider.comENSC Shows Compound Protects Against AbuseApril 15, 2025 | msn.comEnsysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s ThrilledApril 15, 2025 | msn.comEnsysce Biosciences prices 315,188 shares at $3.49 in registered direct offeringApril 1, 2025 | markets.businessinsider.comEnsysce Biosciences Advances in Opioid InnovationMarch 19, 2025 | tipranks.comEnsysce Biosciences announces PAINWeek 2025 SymposiumMarch 18, 2025 | msn.comENSC Starts 2025 in Great ShapeMarch 11, 2025 | msn.comEnsysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation OpioidsMarch 3, 2025 | prnewswire.comEnsysce Biosciences announces continued enrollment in PF614-MPAR trialFebruary 5, 2025 | markets.businessinsider.comWhen Can We Expect A Profit From Ensysce Biosciences, Inc. (NASDAQ:ENSC)?February 4, 2025 | finance.yahoo.comENSC Continues to Announce Potential Life-Changing ResultsJanuary 22, 2025 | msn.comEnsysce Biosciences announces interim data for PF614-MPARJanuary 22, 2025 | markets.businessinsider.comEnsysce Biosciences Inc.: Ensysce Biosciences Issues Annual Shareholder LetterJanuary 8, 2025 | finanznachrichten.deAnson Funds Management LP Buys New Stake in Ensysce Biosciences, Inc. (NASDAQ:ENSC)Anson Funds Management LP bought a new stake in shares of Ensysce Biosciences, Inc. (NASDAQ:ENSC - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 983,518 shares of the company's stock, valued at approximately $236,000. AnsonDecember 8, 2024 | marketbeat.comEnsysce Biosciences Inc.: Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR TrialNovember 26, 2024 | finanznachrichten.deEnsysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR TrialNovember 26, 2024 | finance.yahoo.comEnsysce Biosciences, Inc.: Ensysce Biosciences Reports Third Quarter 2024 Financial ResultsNovember 13, 2024 | finanznachrichten.deENSC Improves PositionNovember 13, 2024 | msn.comEnsysce Biosciences Reports Improved Financial ResultsNovember 13, 2024 | markets.businessinsider.comEnsysce Biosciences receives extension to demonstrate Nasdaq complianceNovember 8, 2024 | markets.businessinsider.comEnsysce Biosciences Announces Leadership Team’s Participation in the Annual Pain Therapeutics SummitOctober 8, 2024 | finance.yahoo.comWhy Nio Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving PremarketSeptember 30, 2024 | benzinga.comEnsysce Biosciences, Inc.: Ensysce Biosciences Submits Phase 3 Protocol to the FDASeptember 19, 2024 | finanznachrichten.deEnsysce Biosciences, Inc.: Ensysce Biosciences Announces IRB Approval for Key MPAR StudyAugust 27, 2024 | finanznachrichten.deBiotech Steals The Show Following $14 Million Grant AnnouncementAugust 27, 2024 | theglobeandmail.comEnsysce Biosciences, Inc.: Ensysce Biosciences Receives $14 Million NIH Grant for Clinical Development of Novel Opioid with Overdose ProtectionAugust 27, 2024 | finanznachrichten.deENSC Treatment Gets Substantial GrantAugust 27, 2024 | msn.comDiamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)August 23, 2024 | globenewswire.comEnsysce Biosciences, Inc.: Ensysce Biosciences Reports Second Quarter 2024 Financial ResultsAugust 15, 2024 | finanznachrichten.deENSC Furthers Important Drug ResearchAugust 15, 2024 | msn.comEnsysce Biosciences, Inc.: Ensysce Biosciences Provides Key Themes Following IASP 2024 SymposiumAugust 8, 2024 | finanznachrichten.deEnsysce Biosciences, Inc. (NASDAQ:ENSC): Are Analysts Optimistic?August 3, 2024 | finance.yahoo.comEnsysce Biosciences, Inc.: Ensysce Biosciences Provides Mid-Year 2024 UpdateJuly 24, 2024 | finanznachrichten.deENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q1 2024June 24, 2024 | investorplace.comSector Update: Health Care Stocks Softer Late AfternoonMay 20, 2024 | finance.yahoo.comEnsysce Biosciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagMay 14, 2024 | finance.yahoo.comENSC: Quarterly Report Highlights ProgressMay 13, 2024 | msn.comEnsysce Biosciences, Inc.: Ensysce Biosciences' CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge MagazineApril 25, 2024 | finanznachrichten.deEnsysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge MagazineApril 25, 2024 | finance.yahoo.comEnsysce Biosciences, Inc.: Ensysce Biosciences to Participate in the Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceApril 9, 2024 | finanznachrichten.deENSC Stock Earnings: Ensysce Biosciences Misses EPS, Beats Revenue for Q4 2023March 18, 2024 | investorplace.comENSC Striding Toward Opioid ReplacementMarch 15, 2024 | finance.yahoo.comEnsysce Biosciences, Inc.: Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 15, 2024 | finanznachrichten.deEnsysce Biosciences Stock (NASDAQ:ENSC), Short Interest ReportFebruary 21, 2024 | benzinga.comEnsysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose ProtectionFebruary 21, 2024 | finance.yahoo.com Get Ensysce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENSC and its competitors with MarketBeat's FREE daily newsletter. Email Address ENSC Media Mentions By Week ENSC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENSC News Sentiment▼0.000.72▲Average Medical News Sentiment ENSC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENSC Articles This Week▼00▲ENSC Articles Average Week Get Ensysce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENSC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CMMB News NAII News DRRX News QNTM News BCTX News ALLR News LPCN News MIRA News CING News UPXI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENSC) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENSC Stock Free ENSC Stock Alerts